Clinical Trials for ABLi Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ABLi Therapeutics

Clinical Trials (1)

NCT05424276
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease
PHASE2Active, not recruiting
120 participants
Started: May 15, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor28 locations